SEARCH

SEARCH BY CITATION

References

  • 1
    McCullough S. Immune-mediated hemolytic anemia: Understanding the nemesis. Vet Clin North Am Small Anim Pract 2003;33:12951315.
  • 2
    Piek CJ, Junius G, Dekker A, et al. Idiopathic immune-mediated hemolytic anemia: Treatment outcome and prognostic factors in 149 dogs. J Vet Intern Med 2008;22:366373.
  • 3
    Grundy SA, Barton C. Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989–1999). J Am Vet Med Assoc 2001;218:543546.
  • 4
    Klein M, Dow S, Rosychuck R. Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: Ten cases (1981–1987). J Am Vet Med Assoc 1989;195:246250.
  • 5
    Reimer ME, Troy GC, Warnick LD. Immune-mediated hemolytic anemia: 70 cases (1988–1996). J Am Anim Hosp Assoc 1999;35:384391.
  • 6
    McManus PM, Graig LE. Correlation between leukocytosis and necropsy findings in dogs with immune-mediated hemolytic anemia: 34 cases (1994–1999). J Am Vet Med Assoc 2001;218:13081313.
  • 7
    Carr AP, Panciera DL, Kidd L. Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: A retrospective study of 72 dogs. J Vet Intern Med 2002;16:504509.
  • 8
    Scott-Moncrieff JC, Treadwell NG, McCullough SM, et al. Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia. J Am Anim Hosp Assoc 2001;37:220227.
  • 9
    Sinnott VB, Otto CM. Use of thromboelastography in dogs with immune-mediated hemolytic anemia: 39 cases (2000–2008). J Vet Emerg Crit Care 2009;19:484488.
  • 10
    Helmond SE, Polzin DJ, Armstrong PJ, et al. Treatment of immune-mediated hemolytic anemia with individually adjusted heparin dosing in dogs. J Vet Intern Med 2010;24:597605.
  • 11
    Weinkle TK, Center SA, Randolph JF, et al. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993–2002). J Am Vet Med Assoc 2005;226:18691880.
  • 12
    Weiss DJ, Brazell JL. Detection of activated platelets in dogs with primary immune-mediated hemolytic anemia. J Vet Intern Med 2006;20:682686.
  • 13
    Breuhl EL, Moore G, Brooks MB, et al. A prospective study of unfractionated heparin therapy in dogs with primary immune-mediated hemolytic anemia. Am Anim Hosp Assoc 2009;45:125133.
  • 14
    Hogan DF, Andrews DA, Green HW, et al. Antiplatelet effects and pharmacodynamics of clopidogrel in cats. J Am Vet Med Assoc 2004;225:14061411.
  • 15
    Schulz KF, Grimes DA. Generation of allocation sequences in randomized trials: Chance, not choice. Lancet 2002;359:515519.
  • 16
    Reagan WJ, Irizarry Rovira AR, DeNicola DB. Appendix 1. In: ReaganWJ, Irizarry RoviraAR, DeNicolaDB, eds. Veterinary Hematology: Atlas of Common Domestic and Non-Domestic Species, 2nd ed. New York: Wiley-Blackwell; 2008;97.
  • 17
    Bennett CL, Connors JM, Carwhile JM, et al. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med 2000;342:177731777.
  • 18
    Hankey GJ. Clopidogrel and thrombotic thrombocytopenic purpura. Lancet 2000;356:269270.
  • 19
    Willens HJ. Clopidogrel-induced mixed hepatocellular and cholestatic liver injury. Am J Ther 2000;7:317318.
  • 20
    CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin patients at risk of ischemic events (CAPRIE). Lancet 1996;348:13291339.
  • 21
    The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494502.
  • 22
    Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: Randomized placebo-controlled trial. Lancet 2005;366:16071621.
  • 23
    Steinhubl SR, Berger PB, Mann JT III, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. J Am Med Assoc 2002;288:24112420.
  • 24
    Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005;352:11791189.
  • 25
    Bhatt DL, Fox KAA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:17061717.
  • 26
    Brainard BM, Kleine SA, Papich SG, et al. Pharmacodynamic and pharmacokinetic evaluation of clopidogrel and the carboxylic acid metabolite SR 26334 in healthy dogs. Am J Vet Res 2010;52:822830.